Metrics Inc. Changes Name to Metrics Contract Services

August 18, 2014
The Daily Reflector

Metrics Contract Services, a full-service contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.  And it is unveiling a new brand look that more clearly identifies Metrics Contract Services as being part of the Mayne Pharma global family.

The new name and brand identity are appropriate for a company poised for significant growth, thanks to the added reach and resources of its global parent, Executive Vice President John S. Ross said.

“We know from market research that Metrics enjoys a great deal of positive brand equity with clients, who associate us with attributes such as quality, reliability, responsiveness and honesty,” Ross said.  “The new Metrics Contract Services brand identity conveys that we’re the same people, delivering the same quality experiences for clients – and that now we’re back by a global pharmaceutical organization with the added resources to deliver even more capabilities.”

With its more descriptive suffix, the name Metrics Contract Services better communicates an ability to deliver a full range of outsources pharmaceutical formulation development and manufacturing capabilities, Ross said.  The new logo – an adaptation of Mayne Pharma’s logo – reflects that Metrics Contract Services is a key component of the global pharmaceutical company.

“Together, Metrics Contract Services and Mayne Pharma make up a bold, modern organization committed to the highest standards of scientific excellence, staff experience and customer satisfaction,” Ross said.  “In support of the continued strength and growth of contract services, the time is right to join identities.”

Mayne Pharma is a publicly traded specialty pharmaceutical company listed on the Australian Securities Exchange.  The company develops and manufactures branded and generic product globally – either directly or through distribution partners – while applying its drug-delivery expertise for contract development and manufacturing services.

Mayne Pharma has a 30-year track record of innovation and success in developing new oral drug delivery systems, and these technologies have been commercialized in numerous products that have been marketed around the world.

Metrics’ areas of expertise include quality formulation development; first-time-in-man formulations; Phase I-III clinical trial materials manufacturing; and analytical method development and validation services leading to commercial scale manufacturing.